SRAIM
BHC icon

Scheer Rowlett & Associates Investment Management’s Bausch Health BHC Stock Holding History

Scheer Rowlett & Associates Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,700
Closed -$377K – 28
2015
Q2 		$377K Buy
+1,700
New +$377K 0.02% 25

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Scheer Rowlett & Associates Investment Management's BHC Position: Q3 2015 in Review

Scheer Rowlett & Associates Investment Management sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 1,700 shares — an estimated $377K sold.

Scheer Rowlett & Associates Investment Management first reported a position in BHC in Q2 2015 and held it in 1 quarter. The position peaked at $377K in Q2 2015. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • Scheer Rowlett & Associates Investment Management reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • Scheer Rowlett & Associates Investment Management sold 1,700 Bausch Health shares in Q3 2015, an estimated $377K.
  • Scheer Rowlett & Associates Investment Management first reported a position in Bausch Health in Q2 2015 and held it in 1 quarter.
  • Scheer Rowlett & Associates Investment Management's Bausch Health position peaked at $377K in Q2 2015.
  • 546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Scheer Rowlett & Associates Investment Management's 13F filing for Q3 2015, filed 16 Nov 2015.